Device Trial Radar · NCT03317665
Observational Biologic or Prosthetic Mesh
Last checked: Nov 19, 2026Latest source record: Oct 6, 2021 (this record)Source: ClinicalTrials.govMethods & limitations
Status
Terminated
Enrollment
28
Actual
Start
Feb 11, 2019
Primary completion
Jun 11, 2021
Study completion Jun 11, 2021
Sponsor
- Lead sponsor
- University of South FloridaAcademic, hospital or other
- Sponsor type
- Academic, hospital or other
- Collaborators
- Integra LifeSciences Corporation
- First posted
- Oct 23, 2017
Design
- Study type
- Observational
- FDA-regulated device
- Yes
- Who can join
- All sexes, from 18 years
- Healthy volunteers
- No
Summary
As written by the sponsor on the registry.
The purpose of this study is to assess the incidence of hernia recurrence with the use of biologic and prosthetic mesh in ventral hernia repair.
Conditions
- Ventral Incisional Hernia
Interventions
Mesh for hernia repairDevice
Permacol, Parietex, Progrip, Strattice Perforated, and Surgimend.
Primary outcomes
What the sponsor says the trial is designed to measure.
- Incidence of ventral hernia recurrenceTime frame: 2 years from study ventral hernia repair
Locations
3 sites in 1 country. Site status is shown where the registry gives one.
Tampa General Hospital
Tampa, Florida
University of South Florida - South Tampa Campus
Tampa, Florida
University of South Florida Morsani Center for Advanced Health Care
Tampa, Florida
Contact details for sites and study staff are not shown here. To ask about taking part, use the contact information on the registry record.
For information only. Nothing on this page is investment, legal, tax or medical advice, and nothing here is an offer to sell or a solicitation of an offer to buy any security. The data comes from public government sources, which can be incomplete, delayed or wrong. Check the original record before relying on it.